High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor

Justin D Lathia , Meizhang Li , Maksim Sinyuk , Alvaro G Alvarado
Cell Reports 6 ( 1) 117 -129

63
2014
Impact on prostate cancer treatment plan quality by MR Linac treatment planning system

R.L. Christiansen , C.R. Hansen , R.H. Dahlrot , A.S. Bertelsen
Radiotherapy and Oncology 127

1
2018
What is the clinical value of cancer stem cell markers in gliomas

Rikke Hedegaard Dahlrot , Simon Kjær Hermansen , Bjarne Winther Kristensen , Steinbjørn Hansen
International Journal of Clinical and Experimental Pathology 6 ( 3) 334 -348

59
2013
Evolution of the gross tumour volume extent during radiotherapy for glioblastomas.

Uffe Bernchou , Uffe Bernchou , Rikke Hedegaard Dahlrot , Carsten Brink
Radiotherapy and Oncology 160 40 -46

2021
Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.

Rikke Hedegaard Dahlrot , Bjarne Winther Kristensen , Mia Dahl Sørensen , Arnon Møldrup Knudsen
Journal of Neuropathology and Experimental Neurology 80 ( 6) 541 -551

2021
Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival

Christoph Patrick Beier , Tine Rasmussen , Rikke Hedegaard Dahlrot , Helene Broch Tenstad
Scientific Reports 8 ( 1) 14965 -14965

3
2018
Plan quality for high-risk prostate cancer treated with high field magnetic resonance imaging guided radiotherapy.

Anders Smedegaard Bertelsen , Olfred Hansen , Carsten Brink , Uffe Bernchou
Physics and Imaging in Radiation Oncology 7 1 -8

6
2018
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.

Sune Munthe , Stine Asferg Petterson , Rikke Hedegaard Dahlrot , Frantz Rom Poulsen
PLOS ONE 11 ( 5)

18
2016
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas

Simon Kjær Hermansen , Rikke Hedegaard Dahlrot , Boye Schnack Nielsen , Steinbjørn Hansen
Journal of Neuro-oncology 111 ( 1) 71 -81

76
2013
High levels of c-Met is associated with poor prognosis in glioblastoma.

Stine Asferg Petterson , Rikke Hedegaard Dahlrot , Simon Kjær Hermansen , Sune K. A. Munthe
Journal of Neuro-oncology 122 ( 3) 517 -527

40
2015
Expression and prognostic value of the WEE1 kinase in gliomas

Darija Music , Rikke Hedegaard Dahlrot , Simon Kjær Hermansen , Jacob Hjelmborg
Journal of Neuro-oncology 127 ( 2) 381 -389

31
2016
Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas

Arnon Møldrup Knudsen , Ida Eilertsen , Susanne Kielland , Mikkel Warming Pedersen
Scientific Reports 10 ( 1) 9285

1
2020
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan

Thomas Urup , Rikke Hedegaard Dahlrot , Kirsten Grunnet , Ib Jarle Christensen
Acta Oncologica 55 ( 4) 418 -422

9
2016
A national study on the inter-observer variability in the delineation of organs at risk in the brain

Ebbe Laugaard Lorenzen , Jesper Folsted Kallehauge , Camilla Skinnerup Byskov , Rikke Hedegaard Dahlrot
Acta Oncologica 60 ( 11) 1548 -1554

14
2021
29
2014
Orbital dekompression ved proptose

Baskaran Ketharanathan , Mikkel Christian Schou Andersen , Christian Bonde Pedersen , Peter Darling
Ugeskr Læger 182 V07200523 -V07200523

2020
Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification

Ljudmilla A. G. Nielsen , Julie A. Bangsø , Kim H. Lindahl , Rikke H. Dahlrot
Diagnostic Pathology 13 ( 1) 38

8
2018
Expression and prognostic value of JAM-A in gliomas.

Ann Mari Rosager , Mia D. Sørensen , Rikke H. Dahlrot , Henning B. Boldt
Journal of Neuro-oncology 135 ( 1) 107 -117

8
2017
A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)

Rikke H. Dahlrot , Bjarne W. Kristensen , Jacob Hjelmborg , Jørn Herrstedt
Journal of Neuro-oncology 114 ( 3) 309 -317

27
2013
Prognostic value of Musashi-1 in gliomas

Rikke H. Dahlrot , Steinbjørn Hansen , Jørn Herrstedt , Henrik D. Schrøder
Journal of Neuro-oncology 115 ( 3) 453 -461

33
2013